Combination of infliximab with thiopurines significantly reduces white cell and neutrophil counts in inflammatory bowel disease patients
Conclusion
Full blood counts should be closely monitored in all patients starting infliximab therapy, in particular patients receiving concomitant thiopurines.
Source: Irish Journal of Medical Science - Category: Journals (General) Source Type: research
More News: Biomedical Science | General Medicine | Inflammatory Bowel Disease | Remicade | Science | Study